Letter to Editor
BibTex RIS Cite

The importance of maternal age in IVF treatment

Year 2020, Volume: 2 Issue: 1, 31 - 32, 30.03.2020

Abstract

The most crucial factor that determines the success of achieving pregnancy both in natural and assisted reproductive techniques is the age of women. The ovarian reserve, which shows the number and quality of residual ovarian follicles, plays a vital role in female fertility, and it is directly related to the female age.

References

  • 1. Yin H, Jiang H, He R, Wang C, Zhu J, Cao Z. Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response. Taiwan J Obstet Gynecol 2019; 58:201-205.
  • 2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014; 123:719-721.
  • 3. La Marca A, Minasi MG, Sighinolfi G, et al. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2017; 108:777-783.e2.
  • 4. Minasi MG, Colasante A, Riccio T, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod 2016; 31:2245-2254.
  • 5. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101:656–663.
  • 6. Ubaldi FM, Cimadomo1 D, Vaiarelli A, et al. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne) 2019; 10:94.
  • 7. Vaiarelli A, Cimadomoa D, Ubaldi N, Rienzia L, Ubaldia FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol 2018; 30:155-162.
  • 8. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26:1768-1774.
  • 9. Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod Biomed Online 2018; 36:435-441.
  • 10. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci 2016; 9:63-69.
  • 11. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol 2007; 165:1380-1388.
  • 12. Leader J, Bajwa A, Lanes A, et al. The Effect of Very Advanced Maternal Age on Maternal and Neonatal Outcomes: A Systematic Review. J Obstet Gynaecol Can 2018; 40:1208-1218.

IVF tedavisinde maternal yaşın önemi

Year 2020, Volume: 2 Issue: 1, 31 - 32, 30.03.2020

Abstract

Gerek doğal yollarla gerekse yardımcı üreme teknikleriyle gebelik elde etme başarısını belirleyen en önemli faktör kadın yaşıdır. Rezidüel ovarian folliküllerin sayısını ve kalitesini gösteren ovarian rezerv, kadın fertilitesinde oldukça önemli rol oynar ve kadın yaşı ile direkt ilişkilidir.

References

  • 1. Yin H, Jiang H, He R, Wang C, Zhu J, Cao Z. Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response. Taiwan J Obstet Gynecol 2019; 58:201-205.
  • 2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014; 123:719-721.
  • 3. La Marca A, Minasi MG, Sighinolfi G, et al. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2017; 108:777-783.e2.
  • 4. Minasi MG, Colasante A, Riccio T, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod 2016; 31:2245-2254.
  • 5. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101:656–663.
  • 6. Ubaldi FM, Cimadomo1 D, Vaiarelli A, et al. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne) 2019; 10:94.
  • 7. Vaiarelli A, Cimadomoa D, Ubaldi N, Rienzia L, Ubaldia FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol 2018; 30:155-162.
  • 8. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26:1768-1774.
  • 9. Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod Biomed Online 2018; 36:435-441.
  • 10. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci 2016; 9:63-69.
  • 11. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol 2007; 165:1380-1388.
  • 12. Leader J, Bajwa A, Lanes A, et al. The Effect of Very Advanced Maternal Age on Maternal and Neonatal Outcomes: A Systematic Review. J Obstet Gynaecol Can 2018; 40:1208-1218.
There are 12 citations in total.

Details

Primary Language Turkish
Subjects Obstetrics and Gynaecology
Journal Section Letter to the Editor
Authors

Runa Özelçi

Yaprak Ustun

Publication Date March 30, 2020
Acceptance Date March 25, 2020
Published in Issue Year 2020 Volume: 2 Issue: 1

Cite

APA Özelçi, R., & Ustun, Y. (2020). IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı Ve Neonatoloji Dergisi, 2(1), 31-32.
AMA Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. March 2020;2(1):31-32.
Chicago Özelçi, Runa, and Yaprak Ustun. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı Ve Neonatoloji Dergisi 2, no. 1 (March 2020): 31-32.
EndNote Özelçi R, Ustun Y (March 1, 2020) IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi 2 1 31–32.
IEEE R. Özelçi and Y. Ustun, “IVF tedavisinde maternal yaşın önemi”, Türk Kadın Sağlığı ve Neonatoloji Dergisi, vol. 2, no. 1, pp. 31–32, 2020.
ISNAD Özelçi, Runa - Ustun, Yaprak. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı ve Neonatoloji Dergisi 2/1 (March 2020), 31-32.
JAMA Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. 2020;2:31–32.
MLA Özelçi, Runa and Yaprak Ustun. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı Ve Neonatoloji Dergisi, vol. 2, no. 1, 2020, pp. 31-32.
Vancouver Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. 2020;2(1):31-2.